Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
David is a food technology company that applies computational protein design and advanced food science to create high-performance nutritional products. Founded by Peter Rahal, the entrepreneur behind RXBAR, the company aims to produce the most protein-dense foods available, starting with its flagship protein bars. By recruiting experts from fields like computational biology and protein engineering, David seeks to innovate at the molecular level to improve the nutritional profile and functionality of food. The company's products are designed for athletes and health-conscious consumers who prioritize a high protein-to-calorie ratio and clean-label ingredients. David represents a shift in the performance nutrition space, blending consumer goods with rigorous scientific methodology to optimize human health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on David Protein.